The In-Vitro Diagnostics (IVD) Market is being driven by Increasing geriatric population, chronic and infectious diseases
The In-Vitro Diagnostics (IVD) Market is expected to grow at a CAGR of 4.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 28.8 billion. The in-vitro diagnostics (IVD) market is witnessing significant growth, particularly in the areas of cancer, cardiovascular diseases (CVD), and infectious kidney diseases, driven by the increasing adoption of advanced immunoassay and molecular diagnostic devices. Healthcare providers are embracing these technologies to deliver precise and timely diagnoses, enabling better treatment outcomes. One such innovation is Siemens' Xprecia Stride Coagulation Analyzer, a handheld device offering high-accuracy PT/INR tests. Meanwhile, the specialty testing segment, including esoteric, pathology, and genetic testing, is projected to outpace the overall market growth. As laboratories prioritize cost-effective solutions, they are increasingly opting for bulk purchases from trusted partners rather than individual analyzers.
Get more information on In-Vitro Diagnostics (IVD) Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
260 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.6% |
Market growth 2025-2029 |
USD 28.8 billion |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
4.3 |
Key countries |
US, Germany, Canada, China, Japan, UK, France, India, Italy, and Brazil |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The In-Vitro Diagnostics (IVD) Market encompasses a range of technologies and tools for the detection, diagnosis, and monitoring of various diseases and conditions. These include diagnostic kits, assay systems, lateral flow assays, ELISA tests, PCR tests, chromatographic techniques, flow cytometry, mass spectrometry, biochip technology, microfluidic devices, antibody development, diagnostic algorithms, decision support systems, specimen collection, sample handling, specimen transport, automated sample processing, data management systems, predictive analytics, precision diagnostics, liquid biopsies, early detection, disease surveillance, public health, global health, emerging infectious diseases, antimicrobial resistance, diagnostic accuracy, quality assurance, validation studies, clinical utility, cost-benefit analysis, economic impact, healthcare policy, and ethical considerations. These advancements in IVD contribute to improved patient outcomes, enhanced disease management, and better population health.
The global life sciences tools and services market encompasses organizations involved in the research and development (R&D) of a diverse range of product categories, including capital equipment, instruments, accessories, and consumables. These tools and services are utilized in the pharmaceutical and biotechnology industries for product development and laboratory diagnosis of various diseases. The market size is determined by the consolidated revenue generated by manufacturers of life science equipment, supplies, pharmaceuticals, biotechnology, and related services. Key growth drivers for this market include the increasing global population aging, leading to a larger demographic requiring healthcare solutions, and the subsequent demand for advanced diagnostic technologies. Specifically, sectors such as Molecular Diagnostics, Serological Tests, Point-of-Care Testing, and Diagnostic Imaging are poised for significant growth due to their ability to provide accurate, timely, and cost-effective diagnostic solutions.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted